 |
|
Exploring molecular targets in diabetic kidney disease
Sayako Maruno, Tetsuhiro Tanaka, Masaomi Nangaku
Kidney Res Clin Pract. 2022;41(Suppl 2):S33-S45. Published online 2022 Mar 15 DOI: https://doi.org/10.23876/j.krcp.21.251
|
|
Citations to this article as recorded by
 Diabetic Macular Edema Is Predictive of Renal Failure in Patients With Diabetes Mellitus and Chronic Kidney Disease
Shih-Hsiang Ou, Wei-Che Chang, Ling-Ying Wu, Shiow-Ing Wang, James Cheng-Chung Wei, Po-Tsang Lee
The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): 761. CrossRef The effect of a methylxanthine vasodilator: pentoxifylline on the treatment of diabetic nephropathy—a meta-analysis
Mingyu Zhang, Yaqing Wang, Wenjing Fu, Li Sun
Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(5): 2777. CrossRef Steps to understanding diabetes kidney disease: a focus on metabolomics
Hyo Jin Kim, Sang Heon Song
The Korean Journal of Internal Medicine.2024; 39(6): 898. CrossRef Association of Estimated Glomerular Filtration Rate With Progression of Albuminuria in Individuals With Type 2 Diabetes
Ko Hanai, Tomomi Mori, Yui Yamamoto, Naoshi Yoshida, Hidekazu Murata, Tetsuya Babazono
Diabetes Care.2023; 46(1): 183. CrossRef Therapieoptionen bei diabetischer Nephropathie
R. Morgenroth, Peter R. Mertens, C. Herzog, Florian G. Scurt
Die Diabetologie.2023; 19(3): 271. CrossRef SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes
Sang Youb Han, Seung Hyun Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Dae Ryong Cha
Life.2023; 13(4): 963. CrossRef Biochanin A Ameliorates Nephropathy in High-Fat Diet/Streptozotocin-Induced Diabetic Rats: Effects on NF-kB/NLRP3 Axis, Pyroptosis, and Fibrosis
Chetan Ram, Shobhit Gairola, Shobhit Verma, Madhav Nilakanth Mugale, Srinivasa Reddy Bonam, Upadhyayula Suryanarayana Murty, Bidya Dhar Sahu
Antioxidants.2023; 12(5): 1052. CrossRef Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis
Chan Ho Kim, Hye-Young Kang, Gyuri Kim, Jimin Park, Bo Young Nam, Jung Tak Park, Seung Hyeok Han, Shin-Wook Kang, Tae-Hyun Yoo
Frontiers in Pharmacology.2023;[Epub] CrossRef Virtual diagnosis of diabetic nephropathy using metabolomics in place of kidney biopsy: The DIAMOND study
Da Woon Kim, Hyo Jin Kim, Eun Young Seong, Sang Soo Kim, Sujin Lee, Suhkmann Kim, Chae Hwa Kwon, Sang Heon Song
Diabetes Research and Clinical Practice.2023; 205: 110986. CrossRef A Novel Risk Score Model for the Differential Diagnosis of Type 2 Diabetic Nephropathy: A Multicenter Study
Yuetong Zhao, Lin Liu, Li Zuo, Xianghai Zhou, Song Wang, Hongwei Gao, Feng Yu, Xiaomei Zhang, Mi Wang, Ling Chen, Rui Zhang, Fang Zhang, Shuhong Bi, Qiong Bai, Jiaxiang Ding, Qinghua Yang, Sixu Xin, Sanbao Chai, Min Chen, Junqing Zhang, Ferdinando Carlo S
Journal of Diabetes Research.2023; 2023: 1. CrossRef Dapagliflozin for the treatment of chronic kidney disease
Yu Kurata, Masaomi Nangaku
Expert Review of Endocrinology & Metabolism.2022; 17(4): 275. CrossRef Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease
Sang Youb Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Dae Young Hur, Han Seong Kim, Dae Ryong Cha
Life.2022; 12(7): 1031. CrossRef Diabetic kidney disease, revisited: where do we stand?
Dae Ryong Cha
Kidney Research and Clinical Practice.2022; 41(Suppl 2): S31. CrossRef TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
Cheol Ho Park, Tae-Hyun Yoo
Pharmaceuticals.2022; 15(12): 1485. CrossRef
|